 The Miami Project faculty is a multidisciplinary team comprised of both basic and clinical scientists with expertise in neuroscience.
Read a Message from the Scientific Director, W. Dalton Dietrich, Ph.D.
|
The Project, published bi-annually is the official magazine of The Miami Project and The Buoniconti Fund and is available electronically. Our Annual Research Review summarizes a selection of research publications from the past year.
|
|
 Our broad scope of collaborative research is dedicated to finding new treatments for spinal cord injury.
Read a Message from the Chairman, Barth A. Green, M.D.
|
Schwann Cell Trial to include Participants with Subacute Spinal Cord Injury
The Miami Project to Cure Paralysis, at the University of Miami Miller School of Medicine has submitted today its first Investigational New Drug (IND) application to the Food and Drug Administration (FDA) requesting permission to begin a Phase I clinical trial to evaluate the safety of autologous human Schwann cell transplantation in the subacute spinal cord injury (SCI) setting.
The clinical protocol of the Phase I trial is strictly focused on safety outcomes. Therefore, the proposed clinical trial is designed to enroll 8 participants with complete thoracic SCI. Newly injured patients would have to meet the stringent inclusion/exclusion criteria and agree to participate in further screening within 5 days after their injury, which is considered the acute phase. At that point, the participant will have a biopsy of a sensory nerve in one leg to obtain his or her own Schwann cells. The Schwann cells will then need to grow in a culturing facility for 3 to 5 weeks to generate the number of cells necessary for transplantation, and to undergo the strict purification process. By the time the Schwann cells are transplanted into the site of spinal cord injury, the participant will be 26-40 days post-injury, which is considered the sub-acute phase.
Led by W. Dalton Dietrich, Ph.D., Scientific Director, The Miami Project to Cure Paralysis, the Schwann cell clinical trial team is comprised of a multi-disciplinary group of faculty level scientists, neurosurgeons, and staff focused on advancing the trial.
Read more
|
|
|
 Years in the making, with unprecedented scientific triumphs, we are actively moving ahead with a Clinical Trials Initiative. Indeed this is an exciting endeavor.
Watch our Video.
|
|
Sunday, May 6 -
Monday, May 7, 2012
Tenth Annual Buoniconti Fund Celebrity Golf Invitational at The Bear's Club
The Bear's Club
Jupiter, Florida
Learn more
Friday, February 3, 2012
(12:00pm-1:00pm)
Gail F. Beach Memorial
Visiting Lectureship Series
Lois Pope LIFE Center Building
7th Floor James K. Batten Apex Auditorium
David Hovda, PhD.
Director, UCLA
Brain Injury Research Center
Professor,
Departments of Neurosurgery
Molecular and Medical Pharmacology
University of California, Los Angeles
“Cerebral Effort In Terms of Traumatic
Brain Injury and Recovery of Function”
Friday, January 27, 2012
(1:00pm-2:00pm)
Neuroscience Center Seminar
Series
Lois Pope LIFE Center Building
7th Floor James K. Batten Apex Auditorium
Emery N. Brown, MD, PhD
Professor
Computational Neuroscience, Health Sciences and Technology
Department of Brain and Cognitive Sciences
MIT-Harvard Division of Health Sciences and Technology
Cambridge, Massachusetts
 Adult and youth wristbands have arrived...Visit our marketplace for these and other items including t-shirts, pens, bags, stress balls and more.
|
|
|